Fc-Binding Protein Antibody Separation for Sugar Chain Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for analyzing antibody sugar chain structures are complex and cannot distinguish minute structural changes, limiting their ability to detect diseases and aging progression effectively.
Innovation Solution
A method using an Fc-binding protein to separate antibodies based on sugar chain structure differences, involving adsorption on an immobilized carrier and elution with an eluent, to obtain a separation pattern for disease detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If LC-MS analysis including cleavage of sugar chains is performed, then sugar chain structures can be analyzed, but the operations become extremely complicated and require an enormous period of time
Solution Approach 1:
The patent extracts and utilizes the Fc region of antibodies as a specific target for separation, focusing only on the relevant portion (Fc region with sugar chains) rather than analyzing the entire antibody molecule. This extraction approach simplifies the analysis by concentrating on the critical sugar chain structures that differ between disease states, thereby reducing operational complexity while maintaining measurement precision.
Solution Approach 2:
The patent introduces an Fc-binding protein as an intermediary substance that selectively binds to the Fc region of antibodies. This intermediary enables the separation and detection of sugar chain structures through affinity chromatography, transforming the complex direct analysis into a simpler indirect process where the Fc-binding protein mediates the interaction between the antibody Fc region and the detection system.
2Productivity
If chromatography analysis is performed to separate antibodies by molecular weight or charge, then separation can be achieved, but minute structural changes such as sugar chain structure changes cannot be distinguished
Solution Approach 1:
The patent applies local quality by focusing the separation mechanism specifically on the Fc region of antibodies, where sugar chain structures are located. The Fc-binding protein is designed to interact selectively with this specific local region, enabling detection of minute structural changes in sugar chains without being distracted by variations in the rest of the antibody molecule. This localized approach enhances measurement precision for structural changes.
Solution Approach 2:
The patent utilizes parameter changes by employing an Fc-binding protein with specific binding affinity characteristics. The separation is based on changes in binding parameters (affinity, binding strength) rather than physical parameters like molecular weight or charge. This parameter-based separation enables detection of subtle structural changes in sugar chains that alter binding affinity, thereby improving measurement precision for structural analysis.
3Ease of manufacture
If existing chromatography methods are used, then antibody separation can be performed, but the methods cannot distinguish minute structural changes and thus provide limited results for disease detection
Solution Approach 1:
The patent introduces an Fc-binding protein as an intermediary that enables reliable detection of disease states through antibody sugar chain analysis. This intermediary substance provides a specific and sensitive mechanism for detecting minute structural changes that are characteristic of disease states, thereby improving reliability for disease detection while maintaining ease of manufacture through a well-defined chromatographic approach.
Solution Approach 2:
The patent replaces conventional mechanical chromatography separation methods (based on molecular weight or charge) with a biochemical interaction-based separation system using Fc-binding protein affinity. This substitution enables the detection of minute structural changes in sugar chains that are invisible to conventional methods, thereby improving reliability for disease detection while keeping the system manufacturable through standard biochemical techniques.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the detection of diseases and aging progression by analyzing the separation pattern of antibodies, providing a simpler and more effective method for disease diagnosis.
Implementation Method 1
adding a solution containing an antibody obtained from the subject to a column filled with an insoluble carrier on which an Fc-binding protein is immobilized, to allow the antibody(ies) to be adsorbed on the carrier
Implementation Method 2
eluting the antibody(ies) adsorbed on the carrier using an eluent, to obtain the data
Data Source
AI summary
An object of the present invention is to provide a method for detecting the presence or absence of a disease, the risk of developing a disease, the degree of progression of a disease and/or the degree of progression of aging, in a subject. The present invention achieves the above described object by a method including the following steps (a) to (c): (a) adding a solution containing an antibody obtained from a subject to a column filled with an insoluble carrier on which an Fc-binding protein is immobilized, to allow the antibody to be adsorbed on the carrier; (b) eluting the antibody adsorbed on the carrier using an eluent, to obtain data of a separation pattern of the antibody; and (c) detecting the presence or absence of a disease, the risk of developing a disease, the degree of progression of a disease and/or the degree of progression of aging, in the subject, using the data as an indicator.


